Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Clinical Lymphoma My...arrow_drop_down
image/svg+xml Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao Closed Access logo, derived from PLoS Open Access logo. This version with transparent background. http://commons.wikimedia.org/wiki/File:Closed_Access_logo_transparent.svg Jakob Voss, based on art designer at PLoS, modified by Wikipedia users Nina and Beao
Clinical Lymphoma Myeloma & Leukemia
Article . 2014 . Peer-reviewed
License: Elsevier TDM
Data sources: Crossref
versions View all 2 versions
addClaim

Small Lymphocytic Lymphoma Presenting As a Paraneoplastic Syndrome With Acute Central Nervous System Demyelination

Authors: Nicholas DeVito; Kit Mui; Yasir Jassam; Lynne Taylor; Monika Pilichowska; Furha Cossor;

Small Lymphocytic Lymphoma Presenting As a Paraneoplastic Syndrome With Acute Central Nervous System Demyelination

Abstract

Chronic lymphocytic leukemia (CLL)/small lymphocytic lym-phoma (SLL) is a mature B-cell neoplasm characterized by accu-mulation of functionally incompetent clonal lymphocytes with thesame morphologic and immunophenotypic features. CLL and SLLhave the same cellular basis but SLL lacks significant peripheralblood (PB) lymphocytosis. CLL is the most common leukemia inthe United States, accounting for 30% of all leukemias, and SLLaccounts for less than 5% of all non-Hodgkin lymphomas. Themedian age at diagnosis is 65 years, and there is a Caucasian malepredominance.

Related Organizations
Keywords

Paraneoplastic Syndromes, Biopsy, Brain, Immunohistochemistry, Leukemia, Lymphocytic, Chronic, B-Cell, Magnetic Resonance Imaging, Diagnosis, Differential, Antibodies, Monoclonal, Murine-Derived, Treatment Outcome, Doxorubicin, Antineoplastic Combined Chemotherapy Protocols, Humans, Prednisone, Female, Lymph Nodes, Rituximab, Tomography, X-Ray Computed, Cyclophosphamide, Aged, Demyelinating Diseases

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    6
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
6
Average
Average
Average
Upload OA version
Are you the author of this publication? Upload your Open Access version to Zenodo!
It’s fast and easy, just two clicks!